Table 1 Baseline Characteristics (safety set)
From: Overnight switch from ropinirole to transdermal rotigotine patch in patients with Parkinson disease
| Â | N = 116 |
|---|---|
Age, yrs ± SD | 60.0 ± 10.1 |
Gender, male, n (%) | 69 (59.5) |
Body weight, kg ± SD | 64.2 ± 9.5 |
BMI, kg/m2 ± SD | 24.2 ± 2.9 |
Duration of PD, yrs ± SD | 5.4 ± 4.0 |
H&Y stage, n (%) | Â |
   1 | 21 (18.1) |
   2 | 69 (59.5) |
   3 | 21 (18.1) |
   4 | 5 (4.3) |
Concomitant PD medication, n (%) | Â |
   Levodopa | 100 (86.2) |
   Amantadine | 61 (52.6) |
   Selegiline | 61 (52.6) |